Other gangliosidosis

This code represents a group of rare, inherited metabolic disorders characterized by the abnormal accumulation of gangliosides in the brain and other tissues, excluding GM1 and GM2 gangliosidosis. These lysosomal storage diseases result from deficiencies in specific enzymes required for ganglioside breakdown, leading to progressive neurological deterioration. Clinical manifestations vary but often include developmental regression, seizures, hepatosplenomegaly, and skeletal abnormalities.

Use this code for documented cases of gangliosidosis that are not specifically identified as GM1 or GM2 types. This typically applies when genetic testing or enzyme assays confirm a gangliosidosis but the specific subtype falls outside of the more common GM1 or GM2 classifications. Documentation should clearly state "other gangliosidosis" or specify a less common type, such as GM3 gangliosidosis.

• Ensure documentation explicitly rules out GM1 (E75.10) and GM2 (E75.11) gangliosidosis before assigning this code.
• Always review genetic testing results or enzyme assay reports to confirm the specific type of gangliosidosis.
• Consider sequencing this code as a primary diagnosis when it is the main reason for the encounter, followed by codes for associated manifestations.